<DOC>
	<DOCNO>NCT00530075</DOCNO>
	<brief_summary>Wegener 's granulomatosis primary systemic vasculitis characterize granulomatous necrotizing inflammation predominantly affect respiratory tract kidney . Conventional therapy Wegener 's granulomatosis cyclophosphamide corticosteroid limit incomplete remission high relapse rate . Patients accumulate irreversible damage due disease consequence prolong drug exposure . The efficacy safety alternative immunosuppressive drug , gusperimus , evaluate patient refractory disease . A prospective , international , nulti-centre , single limb , open label study . Entry require active Wegener 's granulomatosis Birmingham Vasculitis Activity Score ( BVAS ) &gt; =4 previous therapy cyclophosphamide methotrexate . Immunosuppressive drug withdraw entry prednisolone dose adjust accord clinical status . Gusperimus , 0.5mg/kg/day , self-administered subcutaneous injection six treatment cycle 21 day seven day washout cycle . Cycles stop early white blood count &lt; 4,000/mm3 . The primary endpoint complete remission ( BVAS=0 least 2 month ) partial remission ( BVAS &lt; 50 % entry score ) . After sixth cycle azathioprine commence follow-up continued six month .</brief_summary>
	<brief_title>Phase II Study Gusperimus Patients With Refractory Wegener 's Granulomatosis</brief_title>
	<detailed_description />
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Gusperimus</mesh_term>
	<criteria>Documented diagnosis WG accord American College Rheumatology ( ACR ) Chapel Hill Consensus Conference ( CHCC ) definition BVAS &gt; = 4 Total disease duration &gt; = 3 month treat CYC &gt; = 6 month MTX Age 18 80 WBC &gt; = 4,000/mm3 , haemoglobin &gt; = 8g/dl , neutrophil &gt; = 2,500/mm3 , platelet &gt; = 100,000/mm3 ALT , bilirubin alkaline phosphatase level within 2x upper limit normal Documented nonpregnant serum/urine pregnancy test Willing participate study Provide sign informed consent Able prepare selfadminister study drug close friend/relative able Participation another clinical research study Pregnant nursing mother woman childbearing age use appropriate contraception Clear evidence active disease due bacteria/viral infection Patient unacceptable risk participation study immunosuppressive therapy History substance abuse psychotic disorder Previous treatment Gusperimus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Wegener Granulomatosis</keyword>
	<keyword>Vasculitis</keyword>
	<keyword>Gusperimus</keyword>
	<keyword>Immunosuppression</keyword>
</DOC>